Wound Care Global Holdings

What Wound Care Global Holdings does

Wound Care Global Holdings is a Dallas, USA-based private advisory, consulting, and investment firm focused exclusively on the advanced wound care (AWC) vertical. The firm operates through two divisions: Diligence Wound Care Global, which delivers transactional and commercial due diligence to wound care companies and investors, and Advanced Wound Care Global, which supports the launch and operation of wound care service lines and commercialization efforts. The company's go-to-market relies on bespoke advisory engagements, equity-linked participation in portfolio companies, and thought-leadership content (editorial placements, conference faculty roles, podcast appearances).

Its core operating assets are its relationships and intellectual property rather than a packaged software or product. Specifically, the firm reports advisory coverage of approximately 80% of the top 20 global wound care brands and operational involvement with 28 wound care service lines across four continents. It holds or has held positions in a portfolio that includes Siren Care, Compression Works, Corstrata, EZbra, FeelTect, vTail, and XSONX, alongside historical board involvement in Tissue Analytics (acquired by Net Health in 2020) and advisory work on the SastoMed-to-Mölnlycke transaction (2018).

Revenue mechanics are two-fold: advisory and diligence fees from corporate and financial clients, supplemented by investment returns or carry from portfolio positions. The customer base is concentrated in large wound care manufacturers and health systems (named: Medline, Acelity/KCI, ConvaTec, Mölnlycke, SastoMed, Dreamit Ventures, GWU Hospital). With 1-10 employees and no disclosed financial figures, the firm behaves as a high-touch, principal-led boutique rather than a scaled platform.

Name

Wound Care Global Holdings

Legal name

Wound Care Global Holdings LLC

Website

https://woundcare.global

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Short description

Wound Care Global Holdings is a Dallas-based private advisory and investment firm focused exclusively on the advanced wound care vertical, providing diligence, commercialization, and service-line support to manufacturers, providers, and early-stage wound care companies worldwide.

Ownership category

akta.pro rank

Product category

Wound Care Advisory and Investment Services

NAICS

Administrative Management and General Management Consulting Services (541611), Professional, Scientific, and Technical Services (54)

SIC

Services-Management Services (8741), Services-Misc Health & Allied Services, Nec (8090), Services-Health Services (8000)

akta.pro primary industry

Wound Care & Ulcer Management (HLAKACAN)

akta.pro secondary industry

Emergency Response, Spill Prevention & Crisis Preparedness (BPAHAJAM)

Keywords

• Wound care advisory
• Advanced wound care
• Medtech consulting
• Healthcare due diligence
• Wound care investment

Headquarters

HQ city

Dallas

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Strategic Advisory & Due Diligence Services: Fees for strategic and commercial advisory services, due diligence engagements, interim executive roles, and consulting through Diligence Wound Care Global division.
2. Capital Investments & Portfolio Returns: Returns from investments in portfolio companies including Compression Works, Corstrata, EZbra, FeelTect, Siren Care, Tissue Analytics, vTail, XSONX, and others. Investment approach combines advisory/operating involvement with capital allocation, preferring early-stage investments after establishing collaboration relationships.
3. Advanced Wound Care Services & Distribution: Revenue from developing, equipping, managing, and empowering advanced wound care delivery operations in emerging markets through Advanced Wound Care Global division, including service line planning, execution, advisory, and medtech commercial and distribution management.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

WCGH provides specialized strategic and commercial advisory, due diligence, and interim executive services to advanced wound care medtech companies, institutional investors, and healthcare providers through its Diligence Wound Care Global division. Through its Advanced Wound Care Global division, the firm develops, equips, manages, and empowers advanced wound care delivery operations and manages medtech commercialization and distribution in emerging markets such as APAC, LATAM, and MENA. WCGH also deploys capital into early-stage AWC startups, typically after establishing advisory or board relationships.

Product overview

Wound Care Global Holdings operates as a wound care operator, advisor, and investor rather than a traditional product company. The company comprises two primary service brands: Diligence Wound Care Global (strategic/commercial advisory, due diligence, and interim executive services) and Advanced Wound Care Global (AWC service line development and medtech commercialization management). The company maintains a portfolio of wound care and related investments including Tissue Analytics (smartphone wound imaging platform), Compression Works (hemorrhage control device), Corstrata (telehealth wound/ostomy services), EZbra (post-op dressing), FeelTect/Tight Alright (connected compression therapy), Siren Care (smart wearable wound monitoring), vTail (clinical collaboration), and XSONX (wound debridement technology).

Differentiator

Problem solved

Functional benefit

Products and services

• Diligence Wound Care Global Diligence Wound Care Global is WCGH's strategic and commercial advisory plus due diligence service brand. It serves advanced wound care medtech companies, institutional investors, and executives with market intelligence, partnership assessment, competitive intelligence, M&A and pre-investment due diligence, interim executive placements, and business war-gaming/scenario planning for new product launches.
• Advanced Wound Care Global Advanced Wound Care Global is WCGH's service-line development and commercialization management division. It develops, equips, manages, and empowers advanced wound care delivery operations for hospitals and healthcare systems, and provides turnkey distribution and medtech commercialization management for wound care firms entering APAC, LATAM, and MENA markets.

Quantifiable outcome

• Advised 80% of top 20 global wound care medtech brands
• +4 more outcomes

Named customers10 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Dreamit VenturescoreStrategic or Co-development PartnerRafael Mazuz served on Tissue Analytics board at invitation of Dreamit Ventures, providing industry perspectives that strengthened credibility with strategic partners and clients during crucial growth stage leading to Net Health acquisition.
• The George Washington University HospitalminorStrategic or Co-development PartnerRafael Mazuz collaborates with Kara Couch, MS, CRNP, CWCN-AP (President of Association for The Advancement of Wound Care, Director of Wound Care Services at GWU Hospital) on advisory boards, contributing clinical-operational and commercial wound care insights.
• Morgan StanleyminorStrategic or Co-development PartnerRafael Mazuz sat down with Morgan Stanley's US MedTech Equity Managing Director Patrick Wood at NYC global HQ for 'The MedTech Moment' podcast episode discussing investment mistakes and trends in advanced wound care sector.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Health Advances: Health Advances is a healthcare-focused strategy consulting firm serving medtech, biopharma, and diagnostics clients — directly comparable to WCGH in the wound care medtech segment on diligence, commercial strategy, and M&A advisory work.
• Back Bay Life Science Advisors: Back Bay is a boutique strategy and transaction advisory firm dedicated to life sciences and medtech — closely analogous to WCGH in offering healthcare-specialized strategic advisory and due diligence to investors and operators.
• Popper and Company: Popper & Co. is a boutique strategy consulting firm specialized in medtech and digital health — overlaps with WCGH's medtech commercial advisory and digital health diligence work for clients like Tissue Analytics and Siren Care.

Emerging players

• DeciBio Consulting: DeciBio is a precision medicine and healthtech-focused strategy consulting firm offering market intelligence, diligence, and strategic advisory — comparable to WCGH's Diligence Wound Care Global in serving investors and medtech operators, albeit across a broader diagnostics/healthtech remit.
• Defined Health (now Lumanity): Defined Health was a healthcare-focused strategic advisory firm serving emerging medtech, biotech, and digital health clients — close functional overlap with WCGH's strategic and commercial advisory services for wound care innovators.
• S2N Health: S2N Health is a boutique medtech advisory and investment firm providing strategic consulting and capital — highly comparable to WCGH's hybrid advisor-investor model in healthcare vertical specialization.

Broad incumbents

• ZS Associates: ZS Associates is a large global consulting firm with a leading healthcare and medtech practice — a broader-incumbent peer offering commercial strategy and due diligence that overlaps with WCGH on medtech client engagements.
• Trinity Partners: Trinity Partners is an established healthcare and life sciences strategy consulting firm serving pharma, biotech, and medtech — a broader-incumbent comparable to WCGH in delivering commercial diligence and strategy in wound care adjacent verticals.
• LEK Consulting: L.E.K. Consulting is a global strategy firm with a dedicated healthcare practice advising medtech and biopharma on M&A and commercial strategy — a broader-incumbent peer relevant to WCGH's institutional investor and medtech strategy work.

Others

• Muddy Waters Research (expert network consultation comparables): GLG/Guidepoint/Alphasights expert networks are referenced in WCGH's GTM as channels for short-term wound care consultations — adjacent ecosystem participants that compete for the same institutional investor insight spend.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@woundcareglobal
• LinkedInlinkedin.com/company/wound-care-global-holdings-llc

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wound Care Global Holdings